Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award

Published on by Oncology

Assoc. Prof. Dr. Raheleh Farahzadi | Stem Cell Therapy | Women Researcher Award 

Tabriz University of Medical Sciences | Iran

 

Assoc. Prof. Dr. Raheleh Farahzadi is an accomplished biochemist with a PhD and over nine years of experience in higher education, research, and academic leadership in biochemistry, cell, and molecular biology. She is internationally recognized as a top 2% most influential scientist worldwide (Stanford–Elsevier, 2024 and 2025) with a strong research focus on stem cells, cancer biology, and regenerative medicine. She has led 16 university, national, and international research projects and published 69 peer-reviewed articles with an H-index of 35 and over 3,300 citations. An experienced educator, she has delivered diverse biomedical courses and mentored numerous undergraduate, master’s, and PhD students to successful academic outcomes. Her expertise spans advanced cellular, molecular, and stem cell techniques, grant writing, and scientific publishing. She serves as an editor for leading journals and as a reviewer for over 400 manuscripts in high-impact journals. Currently based in Australia, she actively contributes to teaching, research, and collaborative biomedical innovation.

Citation Metrics (Google Scholar)

3374
2500
1500
500
0

Citations

3374

h-index

35

i10-index

58

Citations

h-index

i10-index

View ORCID Profile View Google Scholar Profile
 View ResearchGate Profile

Featured Publications

 

Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award

Published on by Oncology

Prof. Ezzatollah Fathi | Cancer Stem Cell | Best Academic Researcher Award 

 University of Tabriz | Iran 

Prof. Ezzatollah Fathi is a senior academic and biomedical scientist serving as Professor at the University of Tabriz and Academic Sessional Lecturer at Victoria University, Australia, with extensive experience in teaching, research, and academic leadership. He holds a PhD in Clinical Pathology from the University of Tehran and a Doctorate in Veterinary Medicine from Ferdowsi University of Mashhad, both completed with high academic distinction. His teaching expertise covers biochemistry, hematology, clinical pathology, and clinical sciences across undergraduate, postgraduate, and doctoral programs. His research primarily focuses on stem cell biology, regenerative medicine, and cellular and molecular mechanisms of disease. Dr. Fathi has published more than 50 peer-reviewed articles and has served as principal investigator for several national and international research grants. He has supervised numerous undergraduate and postgraduate students, leading to successful theses, publications, and conference presentations. His scholarly impact has been internationally recognized through repeated inclusion in the Stanford–Elsevier list of the world’s top 2% most influential scientists.

Citation Metrics (Scopus)

2054
1500
1000
500
0

Citations

2,054

Documents

79

h-index

34

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile
 View ORCID Profile

Featured Publications

Okechukwu Obulezi | Blood Cancer | Best Paper Award

Published on by Oncology

Dr. Okechukwu Obulezi | Blood Cancer | Best Paper Award 

Lecturer | Nnamdi Azikiwe Univeristy | Nigeria

Dr. Okechukwu Jeremiah Obulezi, Ph.D., is a distinguished statistician whose academic trajectory, research productivity, and multidisciplinary impact make him exceptionally suitable for a Best Paper Award. With a strong foundation in Statistics from Nnamdi Azikiwe University and Abia State Polytechnic, culminating in a Ph.D. focused on developing innovative generalized distribution families through Logistic-X transformations, he has consistently advanced statistical theory and its applications. His research interests span probability distributions, machine learning models, survival analysis, competing risks, acceptance sampling, optimum sampling, mask data and censoring schemes—areas crucial to modern data-driven decision-making in engineering, biomedical sciences, public health, and socio-economic modelling. Dr. Obulezi’s publication record is extensive and impactful, with over forty peer-reviewed journal articles in reputable outlets such as Heliyon, Scientific African, Alexandria Engineering Journal, Entropy, Symmetry, AIP Advances, and Earthline Journal of Mathematical Sciences. His works introduce new probability distributions, propose enhanced estimation techniques, develop sampling plans, and apply machine learning to real-world problems such as financial volatility, disease survival modelling, COVID-19 mortality, rainfall analysis, transportation cost prediction, and biomedical datasets. His methodological sophistication and ability to translate theory into practical applications underscore his scholarly depth. Professionally, he serves as Lecturer I at Nnamdi Azikiwe University and holds several academic leadership roles, including Seminar & Project Coordinator and member of multiple university committees. His international academic influence is further demonstrated through active service as a reviewer for renowned journals under Springer, Elsevier, Taylor & Francis, and Scopus-indexed platforms. Dr. Obulezi’s conference contributions and book chapter reviews further affirm his commitment to advancing statistical knowledge. Collectively, his robust research output, innovative contributions to distribution theory, interdisciplinary relevance, and sustained scholarly engagement establish him as a highly deserving candidate for the Best Paper Award.

Profile: Google Scholar 

Featured Publications

  1. Onyekwere, C. K., & Obulezi, O. J. (2022). Chris-Jerry distribution and its applications. Asian Journal of Probability and Statistics, 20(1), 16–30.

  2. Chinedu, E. C. Q., Chukwudum, Q. C., Alsadat, N., Obulezi, O. J., Almetwally, E. M., & Others. (2023). New lifetime distribution with applications to single acceptance sampling plan and scenarios of increasing hazard rates. Symmetry, 15(10), 1–33.

  3. Orji, G. O., Etaga, H. O., Almetwally, E. M., Igbokwe, C. P., Aguwa, O. C., & Obulezi, O. J. (2025). A new odd reparameterized exponential transformed-X family of distributions with applications to public health data. Innovation in Statistics and Probability, 1(1), 88–118.

  4. Obulezi, O. J., Anabike, I. C., Oyo, O. G., Harrison, E., & Perpetua, I. C. (2023). Marshall-Olkin Chris-Jerry distribution and its applications. International Journal of Innovative Science and Research Technology, 8(5), 1–15.

  5. Anabike, I. C., Igbokwe, C. P., Onyekwere, C. K., & Obulezi, O. J. (2023). Inference on the parameters of Zubair-Exponential distribution with application to survival times of guinea pigs. Journal of Advances in Mathematics and Computer Science, 38(7), 12–35.

By creating forward-looking statistical frameworks with real-world applications, the nominee’s research bridges science and society, enabling smarter policies, stronger industries, and transformative technological progress.

Jun Lu | Cancer | Editorial Board Member

Published on by Oncology

Prof. Jun Lu | Cancer | Editorial Board Member

Professor | Chengdu University of Traditional Chinese Medicine | China

Dr. Jun Lu is a distinguished researcher at Chengdu University of Traditional Chinese Medicine, China, specializing in cancer nanomedicine, biomaterials, and translational therapeutics. His work focuses on the design and development of multifunctional nanoplatforms, including engineered chitosan nanoparticles, aptamer-conjugated chemotherapeutics, and self-gelling biomaterials for applications in tumor therapy, wound healing, and infectious disease management. Dr. Lu integrates molecular biology, materials science, and bioengineering to advance innovative therapeutic strategies, such as modulating tumor microenvironments, orchestrating DNA damage pathways in colorectal carcinoma, and promoting MRSA-infected wound healing. He has authored 78 publications in high-impact journals including Journal of Translational Medicine, Chemical Engineering Journal, Carbohydrate Polymers, and Nano Research, reflecting strong expertise in nanobiotechnology and translational oncology. His extensive collaborations with over 380 co-authors worldwide demonstrate his leadership in multidisciplinary research networks, bridging fundamental science with clinical applications. Beyond academic contributions, Dr. Lu’s work has significant societal impact by enabling advanced therapies for cancer, infectious diseases, and tissue repair, providing novel solutions to global health challenges. His research emphasizes translational relevance and real-world applicability, contributing to safer, more effective, and innovative therapeutic modalities. Dr. Lu’s academic influence and research productivity are reflected in his metrics 2,421 citations, 78 documents, and an h-index of 24.

Profiles: Google Scholar | Scopus | ORCID 

Featured Publications

Lu, J., Zhang, H., Hou, J., Li, X., Hu, X., Hu, Y., Easton, C. D., Li, Q., Sun, C., … (2020). Efficient metal ion sieving in rectifying subnanochannels enabled by metal–organic frameworks. Nature Materials, 19(7), 767–774. Cited by: 495

Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., Zhang, G. (2017). Chemical modifications of nucleic acid aptamers for therapeutic purposes. International Journal of Molecular Sciences, 18(8), 1683. Cited by: 384

Lu, J., Jiang, F., Lu, A., Zhang, G. (2016). Linkers having a crucial role in antibody–drug conjugates. International Journal of Molecular Sciences, 17(4), 561. Cited by: 352

Tan, C. M., Therien, A. G., Lu, J., Lee, S. H., Caron, A., Gill, C. J., Lebeau-Jacob, C., … (2012). Restoring Methicillin-Resistant Staphylococcus aureus susceptibility to β-lactam antibiotics. Science Translational Medicine, 4(126), 126ra35.
Cited by: 328

Li, F., Lu, J., Liu, J., Liang, C., Wang, M., Wang, L., Li, D., Yao, H., Zhang, Q., Wen, J., … (2017). A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer. Nature Communications, 8(1), 1390.
Cited by: 275

 

Global Excellence in Oncology and Cancer Research Award

Published on by Oncology

Introduction: Step into the future of oncology research with the Global Excellence in Oncology and Cancer Research Award. This prestigious accolade honors trailblazers in the field, acknowledging their outstanding contributions to advancing our understanding of cancer and pushing the boundaries of medical science.

Award Eligibility: Open to researchers worldwide, this award is age-neutral and recognizes excellence without boundaries. Eligible candidates should hold a doctoral degree, boast a remarkable publication record, and have significantly impacted the field of oncology.

Evaluation Criteria: Candidates will be evaluated based on the innovation, impact, and quality of their research. A robust publication history, along with demonstrated contributions to the global oncology community, will be key factors in the evaluation process.

Submission Guidelines: To be considered, submit a comprehensive biography, an abstract of your research, and supporting files that illuminate the depth and significance of your work. Strict adherence to the specified format guidelines is essential for a successful submission.

Recognition and Community Impact: Beyond individual accolades, this award recognizes the broader impact of the recipient's work on the global oncology community. Awardees will be acknowledged in high-profile events and publications, amplifying the reach and influence of their contributions.